Mundipharma gains Chinese rights to Helsinn anti-emetic combo
This article was originally published in Scrip
Executive Summary
Mundipharma is to commercialize and distribute in China Nepa, Helsinn's oral fixed-dose combination product for the prevention of chemotherapy-induced nausea and vomiting (CINV).